1-(([1, 1',-BIPHENYL]-2-YL)SULFONYL)-4-FLUORO-N-(3-(METHYLSULFONYL)ALLYL)PIPERIDINE-4-CARBOXAMIDE DERIVATIVES AS RAS-PI3K MODULATORS FOR THE TREATMENT OF E.G. CANCER

申请人

Vividion Therapeutics, Inc.

发明人

TAMIYA, Junko; HORNING, Benjamin; BEDKE, Karl; BERRY, Cynthia; PAN, Chung-Mao; ONDOZABAL, Hideki Miyatake; COOK, Brian

申请日

Feb 26, 2024

公开日

Jan 6, 2026